Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder speaks to Proactive to provide an update on how the company has performed during 2022, and looks ahead to what investors can expect from the coming year.
He says that the company expects to go ahead with launching its erectile dysfunction treatment MED3000 at some point during the first half of 2023.